Natixis Athenex, Inc. Transaction History

Natixis

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$9.44 - $19.8 $421,458 - $883,990	-44,646 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$11.11 - $13.49 $4.78 Million - $5.8 Million	-430,133 Reduced 90.6%	44,646 $553,000
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $4.86 Million - $7.35 Million	474,779 New	474,779 $6.03 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.